MTOR and hyperinsulinism: Furthermore, another concept to be highlighted is that hyperinsulinemia, present in insulin-resistant conditions, may favor IR-A/IGF-2 loop activation, thereby potentiating IR-A-dependent mitogenic functions via MAPK/PI3-K/mTOR signaling activation, and worsening the prognosis of TC [4].